Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 78.13 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $51.000 thousand which missed the analyst consensus estimate of $80.000 thousand by 36.25 percent. This is a 34.62 percent decrease over sales of $78.000 thousand the same period last year.